Paper21058932
Decellularized matrices for tissue engineering.
Hoshiba T and 3 others. Expert Opin Biol Ther, 2010. Cited by 203 papers, by iCite.
Cite this record
ConductScience Library. Decellularized matrices for tissue engineering. Papers, record 21058932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21058932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Matrix | Major topic |
| Regenerative Medicine | Major topic |
| Tissue Engineering | Major topic |
| Tissue Scaffolds | Major topic |
| Animals | |
| Biomimetic Materials | |
| Cells, Cultured | |
| Humans | |
| Regeneration | |
| Stem Cell Transplantation | |
| Stem Cells |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42544260 | Bio-enhanced silk fibroin-based scaffolds for chronic diabetic foot ulcers. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42544260 | PubMed |
| 41023741 | A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41023741 | PubMed |
| 40195414 | Region-specific brain decellularized extracellular matrix promotes cell recovery in an in vitro model of stroke. | Sci Rep | 2025 | https://conductscience.org/library/papers/40195414 | PubMed |
| 39542617 | [Advantages and prospects of cell derived decellularized extracellular matrix as tissue engineering scaffolds]. | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | 2024 | https://conductscience.org/library/papers/39542617 | PubMed |
| 39529738 | LCST/UCST behavior of polysaccharides for hydrogel fabrication. | RSC Adv | 2024 | https://conductscience.org/library/papers/39529738 | PubMed |
| 39194760 | Two Decades of Advances and Limitations in Organ Recellularization. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39194760 | PubMed |
| 38290761 | Tissue-engineered and autologous pericardium in congenital heart surgery: comparative histopathological study of human vascular explants. | Eur J Cardiothorac Surg | 2024 | https://conductscience.org/library/papers/38290761 | PubMed |
| 38006224 | Recent advances in soluble decellularized extracellular matrix for heart tissue engineering and organ modeling. | J Biomater Appl | 2023 | https://conductscience.org/library/papers/38006224 | PubMed |
| 37927899 | Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects. | Bioact Mater | 2024 | https://conductscience.org/library/papers/37927899 | PubMed |
| 37621999 | Recent developments in nanomaterials for upgrading treatment of orthopedics diseases. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37621999 | PubMed |
| 37508817 | Extracellular Matrix-Based and Electrospun Scaffolding Systems for Vaginal Reconstruction. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/37508817 | PubMed |
| 37504838 | Fabrication and Evaluation of Porous dECM/PCL Scaffolds for Bone Tissue Engineering. | J Funct Biomater | 2023 | https://conductscience.org/library/papers/37504838 | PubMed |
| 37064810 | Decellularized Extracellular Matrix for Tissue Engineering (Review). | Sovrem Tekhnologii Med | 2022 | https://conductscience.org/library/papers/37064810 | PubMed |
| 36684103 | Electrically conductive carbon-based (bio)-nanomaterials for cardiac tissue engineering. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36684103 | PubMed |
| 36444341 | In vivo efficacy of a polymer layered decellularized matrix composite as a cell honing cardiovascular tissue substitute. | Mater Today Bio | 2022 | https://conductscience.org/library/papers/36444341 | PubMed |
| 36387956 | Advancements in the Use of Hydrogels for Regenerative Medicine: Properties and Biomedical Applications. | Int J Biomater | 2022 | https://conductscience.org/library/papers/36387956 | PubMed |
| 36342192 | Mid-term performance of decellularized equine pericardium in congenital heart surgery. | Interact Cardiovasc Thorac Surg | 2022 | https://conductscience.org/library/papers/36342192 | PubMed |
| 35735483 | Decellularized Human Umbilical Tissue-Derived Hydrogels Promote Proliferation and Chondrogenic Differentiation of Mesenchymal Stem Cells. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/35735483 | PubMed |
| 35717569 | Quality Comparison of Decellularized Omentum Prepared by Different Protocols for Tissue Engineering Applications. | Cell J | 2022 | https://conductscience.org/library/papers/35717569 | PubMed |
| 35514762 | Biochemical Aspects of Scaffolds for Cartilage Tissue Engineering; from Basic Science to Regenerative Medicine. | Arch Bone Jt Surg | 2022 | https://conductscience.org/library/papers/35514762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21058932
GET https://conductscience.org/api/papers/v1/21058932/cited_by?page=2